PNC Financial Services Group’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$93.6K Buy
2,570
+338
+15% +$10.7K ﹤0.01% 2970
2026
Q1
$62.5K Sell
2,232
-431
-16% -$14.1K ﹤0.01% 3096
2025
Q4
$99.6K Buy
2,663
+619
+30% +$20.4K ﹤0.01% 2807
2025
Q3
$56.3K Sell
2,044
-30
-1% -$1.03K ﹤0.01% 3138
2025
Q2
$65.5K Sell
2,074
-41
-2% -$1.32K ﹤0.01% 2965
2025
Q1
$70.2K Sell
2,115
-213
-9% -$7.64K ﹤0.01% 2893
2024
Q4
$80.1K Buy
2,328
+519
+29% +$17.8K ﹤0.01% 2818
2024
Q3
$72.4K Sell
1,809
-12
-0.7% -$422 ﹤0.01% 2864
2024
Q2
$54.9K Buy
1,821
+325
+22% +$9.77K ﹤0.01% 2975
2024
Q1
$50.2K Sell
1,496
-452
-23% -$14.5K ﹤0.01% 2997
2023
Q4
$62.9K Buy
1,948
+53
+3% +$1.48K ﹤0.01% 2855
2023
Q3
$62.1K Sell
1,895
-4,723
-71% -$164K ﹤0.01% 2835
2023
Q2
$233K Buy
6,618
+854
+15% +$29.5K ﹤0.01% 2099
2023
Q1
$188K Buy
5,764
+1,579
+38% +$71.9K ﹤0.01% 2178
2022
Q4
$231K Buy
4,185
+3,081
+279% +$169K ﹤0.01% 2015
2022
Q3
$49K Buy
1,104
+356
+48% +$17.4K ﹤0.01% 2987
2022
Q2
$36K Buy
748
+401
+116% +$18.1K ﹤0.01% 3181
2022
Q1
$17K Sell
347
-519
-60% -$21.2K ﹤0.01% 3647
2021
Q4
$37K Buy
+866
New +$34.5K ﹤0.01% 3270

Other funds holding HRMY

PNC Financial Services Group's HRMY Position: Q2 2026 in Review

PNC Financial Services Group increased its Harmony Biosciences (HRMY) stake by 15% in Q2 2026, buying an estimated $10.7K and bringing the position to 2,570 shares worth $93.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2970.

PNC Financial Services Group first reported a position in HRMY in Q4 2021 and has held it in 19 quarters since. The position peaked at $233K in Q2 2023. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • PNC Financial Services Group held 2,570 shares of Harmony Biosciences worth $93.6K as of Q2 2026.
  • PNC Financial Services Group bought 338 Harmony Biosciences shares in Q2 2026, an estimated $10.7K.
  • Harmony Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2970 holding.
  • PNC Financial Services Group first reported a position in Harmony Biosciences in Q4 2021 and has held it in 19 quarters since.
  • PNC Financial Services Group's Harmony Biosciences position peaked at $233K in Q2 2023.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.